Last reviewed · How we verify
[U-14C] WX-081
At a glance
| Generic name | [U-14C] WX-081 |
|---|---|
| Also known as | Sudapyridine |
| Sponsor | Shanghai Jiatan Pharmatech Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [U-14C] WX-081 CI brief — competitive landscape report
- [U-14C] WX-081 updates RSS · CI watch RSS
- Shanghai Jiatan Pharmatech Co., Ltd portfolio CI